Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:clvs | https://www.glassdoor.com?employer_id=808732 | 808732 | Apr 28th, 2024 12:00AM | Open | Clovis Oncology | Open | Company - Private | Biotech & Pharmaceuticals | Boulder, CO | 2009 | 3.60 | 52% | 13% | 51% | 4.10 | 3.80 | 3.20 | 4.00 | 4.00 | 3.20 | 3.00 | 3.00 | 3.00 | 3.00 | 12.00 | 24.00 | 28.00 | 32.00 | 12.5% | 12.5% | 12.5% | 12.5% | 50% | 0.00 | 0.00 | 60.00 | 0.70 | 0.30 | 0.60 | 0.30 | 0.10 | Patrick J. Mahaffy | Apr 28th, 2024 04:10PM | Apr 28th, 2024 04:10PM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:clvs | https://www.glassdoor.com?employer_id=808732 | 808732 | Apr 26th, 2024 12:00AM | Open | Clovis Oncology | Open | Company - Private | Biotech & Pharmaceuticals | Boulder, CO | 2009 | 3.60 | 52% | 13% | 51% | 4.10 | 3.80 | 3.20 | 4.00 | 4.00 | 3.20 | 3.00 | 3.00 | 3.00 | 3.00 | 12.00 | 24.00 | 28.00 | 32.00 | 12.5% | 12.5% | 12.5% | 12.5% | 50% | 0.00 | 0.00 | 60.00 | 0.70 | 0.30 | 0.60 | 0.30 | 0.10 | Patrick J. Mahaffy | Apr 26th, 2024 07:55AM | Apr 26th, 2024 07:55AM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:clvs | https://www.glassdoor.com?employer_id=808732 | 808732 | Apr 25th, 2024 12:00AM | Open | Clovis Oncology | Open | Company - Private | Biotech & Pharmaceuticals | Boulder, CO | 2009 | 3.60 | 52% | 13% | 51% | 4.10 | 3.80 | 3.20 | 4.00 | 4.00 | 3.20 | 3.00 | 3.00 | 3.00 | 3.00 | 12.00 | 24.00 | 28.00 | 32.00 | 12.5% | 12.5% | 12.5% | 12.5% | 50% | 0.00 | 0.00 | 60.00 | 0.70 | 0.30 | 0.60 | 0.30 | 0.10 | Patrick J. Mahaffy | Apr 25th, 2024 06:12PM | Apr 25th, 2024 06:12PM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:clvs | https://www.glassdoor.com?employer_id=808732 | 808732 | Apr 24th, 2024 12:00AM | Open | Clovis Oncology | Open | Company - Private | Biotech & Pharmaceuticals | Boulder, CO | 2009 | 3.60 | 52% | 13% | 51% | 4.10 | 3.80 | 3.20 | 4.00 | 4.00 | 3.20 | 3.00 | 3.00 | 3.00 | 3.00 | 12.00 | 24.00 | 28.00 | 32.00 | 12.5% | 12.5% | 12.5% | 12.5% | 50% | 0.00 | 0.00 | 60.00 | 0.70 | 0.30 | 0.60 | 0.30 | 0.10 | Patrick J. Mahaffy | Apr 24th, 2024 10:39AM | Apr 24th, 2024 10:39AM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:clvs | https://www.glassdoor.com?employer_id=808732 | 808732 | Apr 23rd, 2024 12:00AM | Open | Clovis Oncology | Open | Company - Private | Biotech & Pharmaceuticals | Boulder, CO | 2009 | 3.60 | 52% | 13% | 51% | 4.10 | 3.80 | 3.20 | 4.00 | 4.00 | 3.20 | 3.00 | 3.00 | 3.00 | 3.00 | 12.00 | 24.00 | 28.00 | 32.00 | 12.5% | 12.5% | 12.5% | 12.5% | 50% | 0.00 | 0.00 | 60.00 | 0.70 | 0.30 | 0.60 | 0.30 | 0.10 | Patrick J. Mahaffy | Apr 23rd, 2024 04:14PM | Apr 23rd, 2024 04:14PM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:clvs | https://www.glassdoor.com?employer_id=808732 | 808732 | Apr 21st, 2024 12:00AM | Open | Clovis Oncology | Open | Company - Private | Biotech & Pharmaceuticals | Boulder, CO | 2009 | 3.60 | 52% | 13% | 51% | 4.10 | 3.80 | 3.20 | 4.00 | 4.00 | 3.20 | 3.00 | 3.00 | 3.00 | 3.00 | 12.00 | 24.00 | 28.00 | 32.00 | 12.5% | 12.5% | 12.5% | 12.5% | 50% | 0.00 | 0.00 | 60.00 | 0.70 | 0.30 | 0.60 | 0.30 | 0.10 | Patrick J. Mahaffy | Apr 21st, 2024 04:16PM | Apr 21st, 2024 04:16PM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:clvs | https://www.glassdoor.com?employer_id=808732 | 808732 | Apr 20th, 2024 12:00AM | Open | Clovis Oncology | Open | Company - Private | Biotech & Pharmaceuticals | Boulder, CO | 2009 | 3.60 | 52% | 13% | 51% | 4.10 | 3.80 | 3.20 | 4.00 | 4.00 | 3.20 | 3.00 | 3.00 | 3.00 | 3.00 | 12.00 | 24.00 | 28.00 | 32.00 | 12.5% | 12.5% | 12.5% | 12.5% | 50% | 0.00 | 0.00 | 60.00 | 0.70 | 0.30 | 0.60 | 0.30 | 0.10 | Patrick J. Mahaffy | Apr 20th, 2024 04:32PM | Apr 20th, 2024 04:32PM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:clvs | https://www.glassdoor.com?employer_id=808732 | 808732 | Apr 19th, 2024 12:00AM | Open | Clovis Oncology | Open | Company - Private | Biotech & Pharmaceuticals | Boulder, CO | 2009 | 3.60 | 52% | 13% | 51% | 4.10 | 3.80 | 3.20 | 4.00 | 4.00 | 3.20 | 3.00 | 3.00 | 3.00 | 3.00 | 12.00 | 24.00 | 28.00 | 32.00 | 12.5% | 12.5% | 12.5% | 12.5% | 50% | 0.00 | 0.00 | 60.00 | 0.70 | 0.30 | 0.60 | 0.30 | 0.10 | Patrick J. Mahaffy | Apr 19th, 2024 07:28AM | Apr 19th, 2024 07:28AM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:clvs | https://www.glassdoor.com?employer_id=808732 | 808732 | Apr 18th, 2024 12:00AM | Open | Clovis Oncology | Open | Company - Private | Biotech & Pharmaceuticals | Boulder, CO | 2009 | 3.60 | 52% | 13% | 51% | 4.10 | 3.80 | 3.20 | 4.00 | 4.00 | 3.20 | 3.00 | 3.00 | 3.00 | 3.00 | 12.00 | 24.00 | 28.00 | 32.00 | 12.5% | 12.5% | 12.5% | 12.5% | 50% | 0.00 | 0.00 | 60.00 | 0.70 | 0.30 | 0.60 | 0.30 | 0.10 | Patrick J. Mahaffy | Apr 18th, 2024 05:51PM | Apr 18th, 2024 05:51PM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:clvs | https://www.glassdoor.com?employer_id=808732 | 808732 | Apr 17th, 2024 12:00AM | Open | Clovis Oncology | Open | Company - Private | Biotech & Pharmaceuticals | Boulder, CO | 2009 | 3.60 | 52% | 13% | 51% | 4.10 | 3.80 | 3.20 | 4.00 | 4.00 | 3.20 | 3.00 | 3.00 | 3.00 | 3.00 | 12.00 | 24.00 | 28.00 | 32.00 | 12.5% | 12.5% | 12.5% | 12.5% | 50% | 0.00 | 0.00 | 60.00 | 0.70 | 0.30 | 0.60 | 0.30 | 0.10 | Patrick J. Mahaffy | Apr 17th, 2024 02:18PM | Apr 17th, 2024 02:18PM | Clovis Oncology | Health Care | Pharmaceuticals & Biotechnology |